middle.news
Neurotech Boosts Cash Reserves with $2.44M R&D Tax Refund
8:11am on Friday 31st of January, 2025 AEDT
•
Biotechnology
Read Story
Neurotech Boosts Cash Reserves with $2.44M R&D Tax Refund
8:11am on Friday 31st of January, 2025 AEDT
Key Points
Received $2.44 million R&D tax incentive refund for FY24
Cash and equivalents total $6.0 million as of December 31, 2024
Pro-forma cash position stands at $8.44 million post-refund
Ongoing Phase II/III clinical trials in Autism Spectrum Disorder and other paediatric neurological conditions
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Neurotech International (ASX:NTI)
OPEN ARTICLE